Inhibitory effects of antithrombin on the expression of secretory group IIA phospholipase A2 in endothelial cells

Tae Hoon Kim; Jong Sup Bae

doi:10.3858/BMBRep.2010.43.9.604

Inhibitory effects of antithrombin on the expression of secretory group IIA phospholipase A₂ in endothelial cells

Tae Hoon Kim
, Jong Sup Bae

Daegu Haany University

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Tumor necrosis factor-α (TNF-α) mediates proinflammatory responses in primary human umbilical vein endothelial cells (HUVECs), and it upregulates the expression of secretory group IIA phospholipase A₂ (sPLA₂-IIA). sPLA₂-IIA plays a pivotal role in inflammation, and antithrombin (AT) possesses properties that are beneficial to endothelial cells. Therefore, we investigated the effects of AT on the expression of sPLA₂-IIA in TNF-α-stimulated HUVECs. TNF-α potently upregulated the expression of sPLA₂-IIA, and prior treatment of cells with AT inhibited the expression of sPLA₂-IIA in HUVECs. Also, antibodies or siRNA for syndecan-4 blocked the protective effect of AT. Furthermore, PI3-kinase and the AKT pathway are significantly involved in the AT-mediated inhibition of the expression of sPLA₂-IIA. These results show that AT effectively suppresses the upregulated sPLA₂-IIA expression, which might contribute to the cytoprotective effects of AT in the treatment of severe inflammatory diseases.

Original language	English
Pages (from-to)	604-608
Number of pages	5
Journal	BMB Reports
Volume	43
Issue number	9
DOIs	https://doi.org/10.3858/BMBRep.2010.43.9.604
State	Published - Sep 2010

Keywords

Antithrombin
HUVEC
Inflammation
TNF-α
sPLA-IIA

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3858/BMBRep.2010.43.9.604

Cite this

@article{d934b74875464bb58912c283afc2f170,

title = "Inhibitory effects of antithrombin on the expression of secretory group IIA phospholipase A2 in endothelial cells",

abstract = "Tumor necrosis factor-α (TNF-α) mediates proinflammatory responses in primary human umbilical vein endothelial cells (HUVECs), and it upregulates the expression of secretory group IIA phospholipase A2 (sPLA2-IIA). sPLA2-IIA plays a pivotal role in inflammation, and antithrombin (AT) possesses properties that are beneficial to endothelial cells. Therefore, we investigated the effects of AT on the expression of sPLA2-IIA in TNF-α-stimulated HUVECs. TNF-α potently upregulated the expression of sPLA2-IIA, and prior treatment of cells with AT inhibited the expression of sPLA2-IIA in HUVECs. Also, antibodies or siRNA for syndecan-4 blocked the protective effect of AT. Furthermore, PI3-kinase and the AKT pathway are significantly involved in the AT-mediated inhibition of the expression of sPLA2-IIA. These results show that AT effectively suppresses the upregulated sPLA2-IIA expression, which might contribute to the cytoprotective effects of AT in the treatment of severe inflammatory diseases.",

keywords = "Antithrombin, HUVEC, Inflammation, TNF-α, sPLA-IIA",

author = "Kim, \{Tae Hoon\} and Bae, \{Jong Sup\}",

year = "2010",

month = sep,

doi = "10.3858/BMBRep.2010.43.9.604",

language = "English",

volume = "43",

pages = "604--608",

journal = "BMB Reports",

issn = "1976-6696",

publisher = "The Biochemical Society of the Republic of Korea",

number = "9",

}

TY - JOUR

T1 - Inhibitory effects of antithrombin on the expression of secretory group IIA phospholipase A2 in endothelial cells

AU - Kim, Tae Hoon

AU - Bae, Jong Sup

PY - 2010/9

Y1 - 2010/9

N2 - Tumor necrosis factor-α (TNF-α) mediates proinflammatory responses in primary human umbilical vein endothelial cells (HUVECs), and it upregulates the expression of secretory group IIA phospholipase A2 (sPLA2-IIA). sPLA2-IIA plays a pivotal role in inflammation, and antithrombin (AT) possesses properties that are beneficial to endothelial cells. Therefore, we investigated the effects of AT on the expression of sPLA2-IIA in TNF-α-stimulated HUVECs. TNF-α potently upregulated the expression of sPLA2-IIA, and prior treatment of cells with AT inhibited the expression of sPLA2-IIA in HUVECs. Also, antibodies or siRNA for syndecan-4 blocked the protective effect of AT. Furthermore, PI3-kinase and the AKT pathway are significantly involved in the AT-mediated inhibition of the expression of sPLA2-IIA. These results show that AT effectively suppresses the upregulated sPLA2-IIA expression, which might contribute to the cytoprotective effects of AT in the treatment of severe inflammatory diseases.

AB - Tumor necrosis factor-α (TNF-α) mediates proinflammatory responses in primary human umbilical vein endothelial cells (HUVECs), and it upregulates the expression of secretory group IIA phospholipase A2 (sPLA2-IIA). sPLA2-IIA plays a pivotal role in inflammation, and antithrombin (AT) possesses properties that are beneficial to endothelial cells. Therefore, we investigated the effects of AT on the expression of sPLA2-IIA in TNF-α-stimulated HUVECs. TNF-α potently upregulated the expression of sPLA2-IIA, and prior treatment of cells with AT inhibited the expression of sPLA2-IIA in HUVECs. Also, antibodies or siRNA for syndecan-4 blocked the protective effect of AT. Furthermore, PI3-kinase and the AKT pathway are significantly involved in the AT-mediated inhibition of the expression of sPLA2-IIA. These results show that AT effectively suppresses the upregulated sPLA2-IIA expression, which might contribute to the cytoprotective effects of AT in the treatment of severe inflammatory diseases.

KW - Antithrombin

KW - HUVEC

KW - Inflammation

KW - TNF-α

KW - sPLA-IIA

UR - https://www.scopus.com/pages/publications/78649472564

U2 - 10.3858/BMBRep.2010.43.9.604

DO - 10.3858/BMBRep.2010.43.9.604

M3 - Article

C2 - 20846492

AN - SCOPUS:78649472564

SN - 1976-6696

VL - 43

SP - 604

EP - 608

JO - BMB Reports

JF - BMB Reports

IS - 9

ER -